Authors
Latest:
Malignant Melanoma: The Implications of Cost for Stakeholder InnovationAn activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Latest:
Predictive Analytics: A Case Study in Machine-Learning and Claims DatabasesA state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
Latest:
Chronic Care Focus: Diagnosis and Treatment of COPD in Health SystemsControlling chronic obstructive pulmonary disease is a priority for health systems worldwide; recently updated guidelines provide strategies for diagnosis, management, and prevention.
Latest:
Mitigating Drug Diversion Risk: More Than Just Narcotics, Specialty Needs to Look at This Growing ProblemExpensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.
Latest:
Aggressive, Early Treatment Slow MSDefining multiple sclerosis helps pinpoint what therapies work best for patients.
Latest:
Asembia’s 2018 Summit Continues to Enhance the Growth of Specialty PharmacyThe largest annual US health care conference dedicated to specialty pharmacy returns April 29 through May 2, 2018.
Latest:
Lifestyle Changes Could Mitigate Thousands of Cancers Each WeekSmoking and obesity account for a significant number of cancers worldwide.
Latest:
5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk FactorsPalonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Latest:
Preparing for New Rules on Hazardous Drug ManagementMany clinicians have been preparing for USP for a long time and are well on their way to compliance.
Latest:
Study: Intravenous Immunoglobulin Hastens Recovery of Early Onset Guillain-BarreIf IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
Latest:
Part Two: Influential Women in Specialty Pharmacy Help Guide the IndustryThe second half of a 2-part series on the influential women shaping the specialty pharmacy industry.
Latest:
How to Leverage the Revised ASHP Guidelines to Prevent the Diversion of Controlled Substances at HospitalsA controlled substances diversion prevention program (CSDPP) that aligns with the revised ASHP guidelines is critical to ensure patients are protected from occurrences of drug diversion.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
Pharmacists Can Be Invaluable in Identifying Chest PainHelp patients choose appropriate medications and direct them to a physician, when necessary
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Neuropathic Pain: A Glimpse Inside the Unabating AfflictionOriginating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.
Latest:
Be Vigilant With Pediatric PopulationsClinicians often reserve vigilance with drug-related issues for critically ill patients or older populations, while mistaking the resilience of childhood as a protective barrier.
Latest:
4 Pharmacy Operations Missteps to AvoidWhile not everything on this list is a law, they are all at least best practices and/or tips to most efficiently comply with a law or regulation, and to get your job done.
Latest:
Consider New Treatment Options for COPDPharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.
Latest:
Lung Cancers: Facts, Causes, and TypesIn 2017, lung cancer is projected to be the second most prevalent type of cancer in the United States, with about 222,500 new cases and is estimated to still be the leading cause of cancer-related death, with 155,870 deaths.
Latest:
Emerging Trends in Adherence and Quality Measurement: What the Future HoldsAdherence measurement can help patients achieve better outcomes.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
